ANDRES MANUEL R
CERVANTES RUIPEREZ
CATEDRÁTICO/A DE UNIVERSIDAD
Alfredo
Carrato Mena
Publicacions en què col·labora amb Alfredo Carrato Mena (18)
2021
-
First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis
Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231
2012
2011
-
Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma
Cancer Chemotherapy and Pharmacology, Vol. 67, Núm. 1, pp. 75-82
-
Treatment recommendations for metastatic colorectal cancer
Clinical and Translational Oncology, Vol. 13, Núm. 3, pp. 162-178
2009
-
Phase II Trial of Preoperative Irinotecan-Cisplatin Followed by Concurrent Irinotecan-Cisplatin and Radiotherapy for Resectable Locally Advanced Gastric and Esophagogastric Junction Adenocarcinoma
International Journal of Radiation Oncology Biology Physics, Vol. 75, Núm. 5, pp. 1430-1436
2006
-
Guides for adjuvant treatment of colon cancer
Clinical and Translational Oncology, Vol. 8, Núm. 2, pp. 98-102
2005
-
Capecitabine as adjuvant treatment for stage III colon cancer
New England Journal of Medicine, Vol. 352, Núm. 26, pp. 2696-2704
-
Two consecutive phase II trials of biweekly oxaliplatin plus weekly 48-hour continuous infusion of nonmodulated high-dose 5-fluorouracil as first-line treatment for advanced colorectal cancer
Clinical Colorectal Cancer, Vol. 4, Núm. 6, pp. 384-389
2004
-
Phase I/II trial of irinotecan plus high-dose 5-fluorouracil (TTD regimen) as first-line chemotherapy in advanced colorectal cancer
Annals of Oncology, Vol. 15, Núm. 4, pp. 559-567
2003
-
Irinotecan (CPT-11) in Metastatic Colorectal Cancer Patients Resistant to 5-Fluorouracil (5-FU): A Phase II Study
Methods and Findings in Experimental and Clinical Pharmacology, Vol. 25, Núm. 8, pp. 639-643
2000
-
Two consecutive studies using oral UFT-based chemotherapy regimens in elderly patients with advanced colorectal cancer
Clinical and Translational Oncology, Vol. 2, Núm. 3, pp. 154-158
1999
-
UFT Plus or Minus Calcium Folinate for Metastatic Golorectal Cancer in Older Patients
ONCOLOGY, Vol. 13, Núm. 7 SUPPL., pp. 35-40
1998
-
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study
Annals of Oncology, Vol. 9, Núm. 7, pp. 727-731
-
Seventy-two hour epirubicin infusion plus quinidine in unresectable and metastatic adenocarcinoma of the pancreas a phase II trial
American Journal of Clinical Oncology: Cancer Clinical Trials, Vol. 21, Núm. 2, pp. 151-154
1996
-
Outpatient weekly high-dose continuous-infusion 5-fluorouracil plus oral leucovorin in advanced colorectal cancer. A phase II trial
Annals of Oncology, Vol. 7, Núm. 6, pp. 581-585
-
The Spanish experience with high-dose infusional 5-fluorouracil (5-FU) in colorectal cancer. The Spanish Cooperative Group For Gastrointestinal Tumor Therapy (TTD).
The Journal of infusional chemotherapy, Vol. 6, Núm. 3, pp. 118-122
1995
-
A phase II trial of weekly high dose continuous infusion 5‐fluorouracil plus oral leucovorin in patients with advanced colorectal cancer
Cancer, Vol. 76, Núm. 4, pp. 559-563